Can alkaline phosphatase and alanine aminotransferase be elevated in a viral infection with ALP 222 U/L, ALT 69 U/L, lipase 82 U/L, CRP 4 mg/L, and total bilirubin 0.5 mg/dL?

Can ALP and ALT Rise in Viral Infections?

Yes, both alkaline phosphatase (ALP) and alanine aminotransferase (ALT) can be elevated in viral infections, and your specific values (ALP 222 U/L, ALT 69 U/L) represent a mixed hepatocellular-cholestatic pattern that is consistent with viral hepatitis.

Understanding Your Laboratory Pattern

Your laboratory values show:

• ALT 69 U/L: Mildly elevated (approximately 2x upper limit of normal), indicating hepatocellular injury
• ALP 222 U/L: Moderately elevated (approximately 2x upper limit of normal), indicating cholestatic component
• Total bilirubin 0.5 mg/dL: Normal
• CRP 4 mg/L: Mildly elevated, consistent with inflammation
• Lipase 82 U/L: Normal to mildly elevated

This pattern represents a mixed hepatocellular-cholestatic injury rather than pure hepatocellular damage 1.

Viral Infections That Cause This Pattern

Common Viral Causes

Acute viral hepatitis commonly causes ALT elevation, with several viruses also elevating ALP 2, 1:

• Hepatitis A, B, C, E: Can cause both ALT and ALP elevation
• Epstein-Barr Virus (EBV): Frequently causes cholestatic hepatitis with ALP and γ-GT elevation in 38.9% of cases, often with ALT levels similar to yours 3, 4
• COVID-19: Causes abnormal liver chemistries in 70.4% of hospitalized patients, with ALP elevation in 16.1% and ALT elevation being most common 5, 6
• Cytomegalovirus (CMV): Should be considered with marked ALT elevations 2

EBV Hepatitis - A Key Consideration

EBV hepatitis is particularly relevant to your pattern because:

• It causes anicteric cholestatic liver disease in 59% of cases (explaining your normal bilirubin despite elevated ALP) 4
• ALP and γ-GT elevation occurs in approximately 39% of primary EBV hepatitis cases 3
• The mean ALT levels in EBV hepatitis with ALP elevation are around 418 IU/L, but can be as low as your level 3
• Recovery typically occurs within 20-30 days without chronic complications 4

Clinical Interpretation Algorithm

Step 1: Classify the injury pattern

• Your ALT/ALP ratio suggests mixed injury (neither pure hepatocellular nor pure cholestatic) 1
• Mild ALT elevation (<5x upper limit) is classified as "mild" severity 1

Step 2: Determine if viral etiology is likely

• Low CRP (4 mg/L) suggests viral rather than bacterial infection 6
• Normal bilirubin with elevated ALP is characteristic of anicteric cholestatic viral hepatitis 4
• Normal lipase makes primary pancreatic pathology unlikely

Step 3: Investigate specific viral causes

According to guidelines, you should obtain a core liver aetiology screen 2:

• Hepatitis A, B, C, E serologies (especially for ALT >1000 U/L, but reasonable at any elevation) 2
• EBV serology (VCA-IgM, EBNA) - particularly important given your mixed pattern 3, 4
• Consider CMV serology if clinically indicated 2
• COVID-19 testing if respiratory symptoms or exposure 5, 6

Important Clinical Caveats

Do NOT simply repeat the same tests - Guidelines explicitly state that 84% of abnormal liver tests remain abnormal at 1 month, so investigation of etiology is required rather than watchful waiting 2.

Consider non-hepatic ALP sources: While your pattern suggests hepatic origin (given concurrent ALT elevation), ALP can originate from bone, intestine, or placenta. However, the concurrent ALT elevation confirms hepatic involvement 1.

Monitor for progression: While viral hepatitis typically resolves spontaneously, you should:

• Recheck liver enzymes in 2-4 weeks to confirm downward trend 3, 4
• Watch for development of jaundice (though unlikely given your pattern) 4
• Ensure no progression to severe elevation (>10x upper limit) 1

Prognosis

The prognosis for viral hepatitis with your pattern is excellent - EBV hepatitis and most viral causes show complete recovery without chronic complications 3, 4. The mixed cholestatic-hepatocellular pattern may take slightly longer to normalize (17.5 days for ALT, 20-30 days for ALP) compared to pure hepatocellular injury 3, 4.